FI48835C - Menetelmä matolääkkeenä käytettävien beta,beta,beta-trikloorietylideen ijohdannaisten valmistamiseksi. - Google Patents
Menetelmä matolääkkeenä käytettävien beta,beta,beta-trikloorietylideen ijohdannaisten valmistamiseksi.Info
- Publication number
- FI48835C FI48835C FI691055A FI105569A FI48835C FI 48835 C FI48835 C FI 48835C FI 691055 A FI691055 A FI 691055A FI 105569 A FI105569 A FI 105569A FI 48835 C FI48835 C FI 48835C
- Authority
- FI
- Finland
- Prior art keywords
- beta
- trichlorethylene
- preparation
- masking agents
- derivatives useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUEE001505 | 1968-04-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI48835B FI48835B (fi) | 1974-09-30 |
| FI48835C true FI48835C (fi) | 1975-01-10 |
Family
ID=10995250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI691055A FI48835C (fi) | 1968-04-12 | 1969-04-10 | Menetelmä matolääkkeenä käytettävien beta,beta,beta-trikloorietylideen ijohdannaisten valmistamiseksi. |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US3624088A (fi) |
| BE (1) | BE731424A (fi) |
| FI (1) | FI48835C (fi) |
| GB (1) | GB1238416A (fi) |
| IL (1) | IL31989A (fi) |
| SE (1) | SE358156B (fi) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO54786A (fi) * | 1968-01-23 | 1973-02-17 | ||
| US3874874A (en) * | 1970-11-05 | 1975-04-01 | Air Prod & Chem | Herbicidal method employing thiadiazolyl amidines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2653940A (en) * | 1951-01-27 | 1953-09-29 | William S Johnson | Process for preparing 4-quinolyl secondary amines |
| US3000894A (en) * | 1957-10-31 | 1961-09-19 | Diamond Alkali Co | Chloral derivatives of amino quinoline |
| US3002001A (en) * | 1958-04-03 | 1961-09-26 | Sterling Drug Inc | 4-alkylimino-1-[aromatic-(lower - alkyl)]-1,4-dihydroquinolines and their preparation |
| US3374233A (en) * | 1964-08-03 | 1968-03-19 | Searle & Co | N-amino-17alpha-aza-d-homoandrost-5-en-3beta-ol and hydrazones thereof |
| US3501487A (en) * | 1967-06-29 | 1970-03-17 | Mcneilab Inc | Certain hetero-aryl lower alkylene derivatives of 1 - lower alkyl - 2-imino-pyrrolidines |
-
1969
- 1969-04-08 IL IL31989A patent/IL31989A/en unknown
- 1969-04-09 GB GB1238416D patent/GB1238416A/en not_active Expired
- 1969-04-10 US US815238A patent/US3624088A/en not_active Expired - Lifetime
- 1969-04-10 FI FI691055A patent/FI48835C/fi active
- 1969-04-11 SE SE05127/69A patent/SE358156B/xx unknown
- 1969-04-11 BE BE731424D patent/BE731424A/xx unknown
-
1971
- 1971-06-17 US US00154178A patent/US3751423A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SE358156B (fi) | 1973-07-23 |
| FI48835B (fi) | 1974-09-30 |
| GB1238416A (fi) | 1971-07-07 |
| IL31989A0 (en) | 1969-06-25 |
| US3751423A (en) | 1973-08-07 |
| DE1918042B2 (de) | 1975-08-28 |
| BE731424A (fi) | 1969-09-15 |
| DE1918042A1 (de) | 1969-12-11 |
| IL31989A (en) | 1973-01-30 |
| US3624088A (en) | 1971-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK126193B (da) | Analogifremgangsmåde til fremstilling af derivater af substitueret N-amino-indolin. | |
| FI49298C (fi) | Menetelmä masennuslääkkeenä käytettävien 3-aryylioksimetyylipiperidiin ijohdannaisten valmistamiseksi. | |
| FI49716C (fi) | Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi. | |
| FI47572C (fi) | Menetelmä 19-norandrost-4-eeni-3,17-dionien valmistamiseksi. | |
| FI50334C (fi) | Menetelmä 1-hydroksi-2pyridonien valmistamiseksi. | |
| FI47575C (fi) | Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi. | |
| FI46374C (fi) | Menetelmä 2'-substituoitujen steroidi-(17alfa,16alfa-d)-oksatsoliinien valmistamiseksi. | |
| FI52216C (fi) | Menetelmä gamma-piperidinobutyrofenonijohdannaisten valmistamiseksi. | |
| DK125464C (da) | Analogifremgangsmåde til fremstilling af 6-halogen-15β, 16β-methylen-pregnanderivater. | |
| DK120292B (da) | Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater. | |
| FI51183C (fi) | Menetelmä 2-hydroksimetyyli-3-karbonihappoamido-kinoksaliini-di-N-oksi de-(1,4)-yhdisteiden valmistamiseksi. | |
| FI49161C (fi) | Menetelmä kardenolidi-3-(2´,3´-didesoksi-2´,3´-oksido-glykosidien) val mistamiseksi. | |
| FI48835C (fi) | Menetelmä matolääkkeenä käytettävien beta,beta,beta-trikloorietylideen ijohdannaisten valmistamiseksi. | |
| FI46727C (fi) | Menetelmä pyridatsolijohdannaisten valmistamiseksi. | |
| FI48088C (fi) | Menetelmä 5-fenyyli-1H-1,4-bentsodiatsepiini-johdannaisten valmistamis eksi | |
| FI47576C (fi) | Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi. | |
| FI51180C (fi) | Analogiamenetelmä anti-Trichomonas-aktiviteetin omaavien 2-nitro-imida tsoli-johdannaisten valmistamiseksi. | |
| FI47349C (fi) | Menetelmä 17alfa-propadienyyli-17beta-hydroksi-steroidien valmistamise ksi. | |
| FI49160C (fi) | Menetelmä 6alfa-fluori-16alfa,18-dimetyyli-1,4-pregnadien-3,20-dionijo hdannaisten valmistamiseksi. | |
| FI52088C (fi) | Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi. | |
| FI46385C (fi) | Menetelmä terapeuttisesti arvokkaiden 1,3-dihydro-3-hydroksi-2H-1,4-be ntsodiatsepiini-2-onijohdannaisten valmistamiseksi. | |
| FI44621C (fi) | Menetelmä hypertensiivisten 3,4-dihydroksifenyylipropaani-johdannaiste n valmistamiseksi. | |
| FI46724C (fi) | Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi. | |
| FI51814C (fi) | Menetelmä alfa-karboksibentsyylipenisiliinin kielteisen alkalimetallis uolojen valmistamiseksi. | |
| FI46384C (fi) | Menetelmä lääkeaineina vaikuttavien adenosiinijohdannaisten valmistami seksi. |